Single daily tobramycin dosing in cystic fibrosis: is it better for the patients or the bugs?

Lancet. 2005 Feb;365(9459):547-8. doi: 10.1016/S0140-6736(05)17919-7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacokinetics
  • Child
  • Chronic Disease
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / microbiology*
  • Cystic Fibrosis / physiopathology
  • Drug Administration Schedule
  • Humans
  • Microbial Sensitivity Tests
  • Pseudomonas Infections / complications
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas aeruginosa / drug effects
  • Tobramycin / administration & dosage*
  • Tobramycin / adverse effects
  • Tobramycin / pharmacokinetics

Substances

  • Anti-Bacterial Agents
  • Tobramycin